m+Medelevator.RU
← Поиск публикаций
World journal of urology · 2025

Impact of intra-abdominal pressure with AirSeal® system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomy.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Buhas Bogdan Adrian, Skowron Olivier, Sié Martin, de Vergie Stéphane, Potiron Eric, Miaadi Naoufel, Pasticier Gilles, Vuong Nam-Son, Brureau Laurent, Almeras Christophe, Azancot Vidal, Beauval Jean-Baptiste, Belas Olivier, De Fourmestraux Aude, Bommelaere Thomas, Deffar Nordine, Gourtaud Gilles, Guillotreau Julien, Nguyen Truong An, Pashootan Pourya, Poinas Grégoire, Peyrottes Arthur, Rouffilange Jean, Roumiguié Mathieu, Rouvellat Philippe, Van Hove Antoine, Pettenati Caroline, Pradère Benjamin, de la Taille Alexandre, Fiard Gaëlle, Dariane Charles, Ploussard Guillaume

Аннотация

PURPOSE: To evaluate the impact of the AirSeal® insufflation system on postoperative pain, analgesic consumption, and patient satisfaction following robot-assisted radical prostatectomy (RARP), using real-world patient-reported outcomes (PROMs) collected via a digital health platform.

METHODS: This retrospective multicenter study included 312 patients undergoing RARP for localized prostate cancer across 19 French centers (September 2024-June 2025). Forty-seven patients (15.1%) underwent RARP with AirSeal® (low or standard pressure) and 265 (84.9%) with conventional insufflation (standard pressure). Pain scores, measured using the Visual Analogue Scale and analgesic use were recorded daily from postoperative day (POD) 1-14 via the CE-certified Betty Coaching smartphone application. Secondary outcomes included length of stay, sick leave duration, patient satisfaction at 6 weeks, and postoperative complications.

RESULTS: Baseline characteristics were comparable between groups. Median pain scores were consistently lower with AirSeal®, with complete pain resolution by POD8 versus POD14 for conventional insufflation. By POD8, all AirSeal® patients were analgesic-free, compared to 83% at POD14 in the control group. All patients were opioid-free within 2 weeks. Hospital stay (median 1 day) and satisfaction (median score 10/10) were similar. Complication rates (10.6% vs. 6.8%, p = 0.352) and readmissions did not differ significantly.

CONCLUSION: Use of the AirSeal® system in RARP was associated with faster pain resolution and earlier cessation of analgesics without compromising perioperative safety. Digital PROMs collection via the Betty Coaching platform offers precise recovery monitoring, reinforcing its role in enhanced recovery pathways and supporting the integration of valveless insufflation technology into minimally invasive urologic surgery.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты